TNTandem Diabetes Care, Inc. TNDM · NASDAQ
$17.15 +4.89% (+$0.80)
- Market cap
- $1.14B
- Enterprise value
- $1.82B
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 1.1x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -4.8%
- Gross margin
- 56.0%
- Net margin
- -6.1%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 1.66
- Free float
- 91.6%
About the company
Tandem Diabetes Care is a U.S.-based company specializing in the development and manufacturing of innovative devices for diabetes management. The company is particularly known for its technology in continuous glucose monitoring and insulin pumps, which assist patients with diabetes in managing their condition more effectively. Tandem Diabetes Care focuses on providing user-friendly and technologically advanced solutions that improve the quality of life for diabetics and make daily management of their treatment easier.
Sector
Healthcare
Industry
Medical - Devices
CEO
John F. Sheridan
Employees
2,500
Headquarters
San Diego
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number